Literature DB >> 23062936

Severely recalcitrant pyoderma gangrenosum successfully treated with ustekinumab.

Ari M Goldminz, Nina C Botto, Alice B Gottlieb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23062936     DOI： 10.1016/j.jaad.2012.04.045

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  9 in total

Review 1.  Surgical Treatment of Pyoderma Gangrenosum with Negative Pressure Wound Therapy and Skin Grafting, Including Xenografts: Personal Experience and Comprehensive Review on 161 Cases.

Authors:  Klaus Eisendle; Tobias Thuile; Jenny Deluca; Maria Pichler
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-04-28       Impact factor: 4.730

2.  Successful treatment of refractory pyoderma gangrenosum with ustekinumab only after excision of renal cell carcinoma.

Authors:  Ioana Cosgarea; Zdenka Lovric; Andreas Körber; Joachim Dissemond
Journal:  Int Wound J       Date:  2014-10-08       Impact factor: 3.315

3.  Pyoderma gangrenosum: From historical perspectives to emerging investigations.

Authors:  Misty M Hobbs; Alex G Ortega-Loayza
Journal:  Int Wound J       Date:  2020-05-06       Impact factor: 3.315

4.  Increased Demand for Therapeutic Drugs in Pediatric Ulcerative Colitis Patients With Extraintestinal Manifestations.

Authors:  Yiyoung Kwon; Eun Sil Kim; Yon Ho Choe; Mi Jin Kim
Journal:  Front Pediatr       Date:  2022-05-23       Impact factor: 3.569

5.  Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi-systematic review.

Authors:  Hakim Ben Abdallah; Karsten Fogh; Rikke Bech
Journal:  Int Wound J       Date:  2019-01-03       Impact factor: 3.315

Review 6.  Next generation of biologics for the treatment of Crohn's disease: an evidence-based review on ustekinumab.

Authors:  Aranzazu Jauregui-Amezaga; Michael Somers; Heiko De Schepper; Elisabeth Macken
Journal:  Clin Exp Gastroenterol       Date:  2017-11-15

Review 7.  Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments.

Authors:  Carlo Alberto Maronese; Matthew A Pimentel; May M Li; Alex G Ortega-Loayza; Angelo Valerio Marzano; Giovanni Genovese
Journal:  Am J Clin Dermatol       Date:  2022-05-24       Impact factor: 6.233

8.  Successful Treatment of a Patient with Pyoderma Gangrenosum, Plaque Psoriasis and Palmoplantar Pustulosis with Adalimumab.

Authors:  Yuqi Chu; Taoming Liu; Juan Bai; Hong Fang; Jianjun Qiao
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-09-20

Review 9.  Ustekinumab in treatment of Crohn's disease: design, development, and potential place in therapy.

Authors:  Parakkal Deepak; Edward V Loftus
Journal:  Drug Des Devel Ther       Date:  2016-11-11       Impact factor: 4.162
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.